Increased erythrocyte phosphatidylserine exposure in chronic renal failure

Journal of the American Society of Nephrology

Volumn 10, Issue 9, 1999, Pages 1982-1990

  Bonomini, Mario ^a,c   Sirolli, Vittorio ^a   Settefrati, Nicola ^a   Dottori, Secondo ^b   Di Liberato, Lorenzo ^a   Arduini, Arduino ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Sigma Tau SpA   (Italy)

^c SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CREATININE; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLSERINE; THROMBIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE MEMBRANE; ERYTHROPHAGOCYTOSIS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHOSPHOLIPID TRANSFER; PLASMA FACTOR; PRIORITY JOURNAL; UREMIA;

EID: 0032773209     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1091982     Document Type: Article

References (42)

1. Eschbach JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35: 134-148, 1989
2. Joske RA, McAlister JM, Prankerd TAJ: Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sci 15: 511-522, 1956
3. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276: 653-658, 1967
4. Shaw AB: Haemolysis in chronic renal failure. Br Med J 2: 213-216 1967
5. Massry SG: Pathogenesis of the anemia of uremia: Role of secondary hyperparathyroidism. Kidney Int 16[Suppl 24]: 204-207, 1983
6. Bretscher MS: Asymmetric lipid bilayer structure for biological membranes. Nat New Biol 236: 11-12, 1972
7. Devaux PF, Zachowski A: Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids 73: 107-120, 1994
8. Zwaal RFA, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132, 1997
9. Tanaka Y, Schroit AJ: Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells: Recognition by autologous macrophages. J Biol Chem 258: 11335-11343, 1983
10. McEvoy L, Williamson P, Schlegel RA: Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci USA 83: 3311-3315, 1986
11. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT-Y, Lubin B, Schroit AJ: Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 75: 1965-1972, 1985
12. Lubin B, Chiu D, Bastacky J, Roelofsen B, VanDeenen LLM: Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest 67: 1643-1649, 1981
13. Tait JF, Gibson D: Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 123: 741-748, 1994
14. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH: Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 87: 1179-1187, 1996
15. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations. Blood 88: 1873-1880, 1996
16. Cole CH, Balfe JW, Welt LJ: Induction of a ouabain-sensitive ATPase defect by uremic plasma. Trans Assoc Am Physiol 81: 213-220, 1968
17. Inauen W, Staubli M, Descoeudres C, Galeazzi L, Straub PW: Erythrocyte deformability in dialysed and non-dialysed uraemic patients. Eur J Clin Invest 12: 173-176, 1982
18. Corry DB, Lee DBM, Tuck ML: A kinetic study of cation transport in erythrocytes from uremic patients. Kidney Int 32: 256-260, 1987
19. 3 anion exchanger in erythrocytes of uraemic patients. Nephrol Dial Transplant 5: 1018-1022, 1990
20. Lindner A, Gagne E-R, Zingraff J, Jungers P, Drueke TB, Hannaert P, Garay R: A circulating inhibitor of the RBC membrane calcium pump in chronic renal failure. Kidney Int 42: 1328-1335, 1992
21. Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG: Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. J Clin Invest 91: 2497-2503, 1993
22. Wilson MJ, Richter-Lowney K, Daleke DL: Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 32: 11302-11310, 1993
23. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265: 4923-4928, 1990
24. Serke S, Huhn D: Identification of CD71 (transferrin receptor) expressing erythrocytes by multiparameter-flow-cytometry (MP-FCM): Correlation to the quantitation of reticulocytes as determined by conventional microscopy and by MP-FCM using a RNA-staining dye. Br J Haematol 81: 432-439, 1992
25. Daleke DL, Huestis WH: Erythrocyte morphology reflects the transbilayer distribution of incorporated phospholipids. J Cell Biol 108: 1375-1385, 1989
26. Boyum A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21: 77-89, 1968
27. Zachowski A: Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement. Biochem J 294: 1-14, 1993
28. Schroit AJ, Zwaal RFA: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1071: 313-329, 1991
29. Sheetz MP, Singer SJ: Biological membranes as bilayer couples: A mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 71: 4457-4461, 1974
30. Zappacosta AR, Caro J, Erslev A: Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 72: 53-57, 1982
31. Fontanellas A, Coronel F, Santos JL, Herrero JA, Moran MJ, Guerra P, Tornero F, Enriquez de Salamanca R: Heme biosynthesis in uremic patients on CAPD or hemodialysis. Kidney Int 45: 220-223, 1994
32. Niwa T, Yazawa T, Kodoma T, Uehara Y, Maeda K, Yamada K: Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 56: 241-245, 1990
33. Osada J, Gea T, Sanz C, Millan I, Botella J: Evaluation of dialysis treatment in uremic patients by gel filtration of serum. Clin Chem 36: 1906-1910, 1990
34. Seigneuret M, Devaux PF: Asymmetric distribution of spinlabeled phospholipids in the erythrocyte membrane: Relation to shape changes. Proc Natl Acad Sci USA 81: 3751-3755, 1984
35. Connor J, Schreit AJ: Aminophospholipid translocation in erythrocytes: Evidence for the involvement of a specific transporter and an endofacial protein. Biochemistry 29: 37-43, 1990
36. Gafter U, Malachi T, Barak H, Djaldeti M, Levi J: Red blood cell calcium homeostasis, in patients with end-stage renal disease. J Lab Clin Med 114: 222-231, 1989
37. Bitbol M, Fellmann P, Zachowski A, Devaux PF: Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 904: 268-282, 1987
38. Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J: Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69: 1017-1025, 1982
39. Zwaal RFA, Comfurius P, VanDeenen LLM: Membrane asymmetry and blood coagulation. Nature 268: 358-360, 1977
40. Jackson CM, Nemerson Y: Blood coagulation. Annu Rev Biochem 49: 765-811, 1980
41. Thiagarajan P, Tait JF: Binding of annexin V/placental anticoagulant protein I to platelets: Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 265: 17420-17423, 1990
42. Druml W, Kelly RA, May RC, Mitch WE: Abnormal cation transport in uremia: Mechanisms in adipocytes and skeletal muscle from uremic rats. J Clin Invest 81: 1197-1203, 1988